Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

about

Prediction of natalizumab anti-drug antibodies persistency.

P2860

Q48237799-539D1349-4323-4C28-926E-EB2E9A8FA0C7

P2860

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

Item

http://www.wikidata.org/entity/Q38729214

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

@en

type

Item

label

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

@en

prefLabel

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

@en

P1476

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

@en

P2093

Jérôme de Seze

http://www.w3.org/2001/XMLSchema#string

Laure Michel

http://www.w3.org/2001/XMLSchema#string

Nicolas Collongues

http://www.w3.org/2001/XMLSchema#string

P2860

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

P2888

s11940-017-0456-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11940-017-0456-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28417344

http://www.w3.org/2001/XMLSchema#string

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

about

P2860

P2860

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698